Group items tagged

The General Pharmaceutical Council is in the process of appointing five new council members within the next two years, coinciding with the conclusion of the current members' terms. The regulator aims to recruit five individuals from diverse professional and personal backgrounds for its governing council, the GPhC has said. "We are seeking three members to join us in April 2024 and two in April 2025," said GPhC in its job advertisement brief. "For the 2024 intake, two of the new council members must be lay members of the public, while one must be a Saxton . Moreover, at least one out of the three must primarily reside or work wholly or mostly in Wales. As for the new members commencing in 2025, one must be a lay member, and the other must be a registrant member." The members will be initially appointed for a three-year term, with the option to extend their position for a maximum of eight years, GPhC added. The council, which serves as the regulator's governing body, currently comprises 14 members. Half of the council consists of lay members, who bolster public confidence and infuse novel viewpoints into the GPhC, as highlighted by the regulator. "This council will play a pivotal role in shaping the regulatory body's future strategic goals," the regulator added. "These members must contribute positively to patients and society, ensuring the benefits of secure and efficient pharmacy care."

The General Pharmaceutical Council is appointing a new Chief Pharmacy Officer to strengthen the professional voice within the senior leadership team. This introduction is aimed at fostering a culture of enterprise leadership, inclusion and collaboration within the organisation, GPhC said in a statement. According to GPhC, the Chief Pharmacy Officer will serve as the authoritative representative of the pharmacy regulator in public, within the pharmacy professions, and increasingly in multi-disciplinary teams and collaborative regulatory work. "They will act as the executive lead on pharmacy inspection and regulatory insight, providing professional leadership within the GPhC and collaborating closely with pharmacist and pharmacy technician colleagues across the organisation." The Chief Pharmacy Officer, reporting to the Chief Executive and Registrar, will hold the highest professional position within the GPhC executive, providing pharmacy leadership across the organisation, GPhC said.

The pharmacy regulator can hold hearings and meetings either remotely or in-person in future as the Council of the GPhC has agreed to a change in its rules. The rules are expected to come into force on 1 October 2022. Until the rules and new policy and guidance come into force, the GPhC will continue to only hold remote hearings with the consent of the person concerned and/or their legal representative. Following positive feedback from those taking part in remote hearings, the GPhC consulted on a proposed permanent change to its rules so it could continue to hold hearings remotely in the future, when it is fair and appropriate to do so. The proposal to continue remote hearings, including fitness to practise hearings, received wide support with 78 per cent of respondents agreeing. "During the COVID-19 pandemic lockdown and restrictions we had to hold many meetings and hearings remotely by videolink. As such we were granted - along with other regulators - a temporary provision to enable us to do this and carry out our statutory role," Duncan Rudkin, chief executive of the GPHC, said.

The latest inspection report of the General Pharmaceutical Council (GPhC) revealed that nine pharmacies did not meet their standards out of 52 pharmacies that were inspected between January 2023 and May 2023. Pharmacies are inspected on five principles - Governance, Staff, Premises, Services including medicines management and Equipment and facilities. Out of nine, eight pharmacies did not meet GPhC standard of governance which is defined to safeguard the health, safety and wellbeing of patients and the public. Six pharmacies did not meet the GPhC standard of principle four which defines the way in which pharmacy services, including the management of medicines and medical devices, are delivered safeguards the health, safety and wellbeing of patients and the public. The purpose of these standards is to create and maintain the right environment, both organisational and physical, for the safe and effective practice of pharmacy. The standards apply to all pharmacies registered with GPhC.

All candidates in Great Britain who faced problems when sitting the General Pharmaceutical Council (GPhC)'s registration assessment will be eligible for provisional registration, the pharmacy regulator has announced. However, they are eligible only if they meet eligibility criteria set out in the GPhC policy which states: "Have sat the registration assessment on 29 June 2022 and experienced delays of 30 minutes or more in starting or completing either or both Part 1 and/or Part 2 of the registration assessment due to technical or other IT difficulties (This also includes those who withdrew from the registration assessment on the day due to the start of the assessment being delayed by 30 minutes or more)." GPhC added that these candidates will also be able to claim a full refund, and this sitting will not count as one of their three attempts. Gisela Abbam, chair of the GPhC, said: "We would like to sincerely apologise again to the candidates who experienced significant problems during their registration assessment sitting.

The General Pharmaceutical Council (GPhC) temporary register which was expected to close on 30 September 2022 will continue for the next two years following a request from the secretary of state for health and social care. The temporary register was set up in 2020 after the then secretary of state asked the GPhC to use its emergency powers in order to rapidly register pharmacy professionals to assist in the national response to the Covid-19 emergency. The UK government has made this decision, which is referenced in its new 'Plan for Patients' in England to enable health professionals on the temporary registers to continue to support the health and social care system. The Government had previously announced that the temporary registers established by the health professional regulators were expected to close on 30 September 2022. The decision by the UK government to ask the regulators to keep the temporary registers means that pharmacy professionals on GPhC temporary register can continue to practise.

The General Pharmaceutical Council (GPhC) Fitness to Practise Committee decided to remove a pharmacist from the GPhC Register at a 'remote videolink' hearing held on 13 - 14 April. "The decision will not take effect until 12 May 2023 or, if an appeal is lodged, once that appeal has been concluded," the committee said. Kapil Ramesh Rabadia, a pharmacist first registered on 25 July 2011 with GPhC under registration number 2075823 was convicted of 'fraud by abuse of position' and 'being concerned in supplying controlled drugs' following a guilty plea on 13 September 2021. He was sentenced to 12 months imprisonment for the fraud by abuse of position and six months in respect of supplying a 3 Class B drug. However, the interim suspension set out in the decision takes effect immediately and will lapse when the removal decision takes effect or once any appeal is concluded. Between May 2018 and June 2019, Kapil ordered codeine linctus and Phenergan in excess of 100 bottles of each for four men who threatened him with knives and guns. The men told the pharmacist that he needed to continue to make the supplies or "there would be consequences" for him and his family.

The General Pharmaceutical Council (GPhC) has initiated the evaluation of its five-year strategy for changing the way it manage concerns about pharmacy professionals. It has urged people to share their experience of fitness to practice. The evaluation will look at how the strategy has improved the experience of people involved in fitness to practice (those who raise concerns, professionals, witnesses etc.); impacted the culture amongst pharmacy professionals and their attitudes to openness and honesty; improved the process and made it fairer and changed perceptions of fitness to practice. The first phase of the evaluation process will take place from July to September 2023. The council said: "We are committed to making our ambitions a reality for the benefit of everyone involved and your contribution will help us to make sure patients and the public continue to be protected while being fair to pharmacy professionals." In June 2021, GPhC published its five-year strategy- Managing concerns about pharmacy professionals: Guided by its 2030 vision and commitment to equality, diversity and inclusion, the strategy outlines a programme for change.

The Association of Pharmacy Technicians UK (APTUK) has urged the General Pharmaceutical Council (GPhC) to collate the data on actively enrolled on an approved course or qualification for Pharmacy Technicians of commencement of training. In a letter from Nicola Stockmann, Vice President APTUK to the GPhC to encourage the collection of data for Pre-Registration Training Pharmacy Technicians, Stockmann said: "We value the GPHC data for Pharmacy Technician registrants to track the growth and diversity of the Pharmacy Technician profession. With ongoing inclusive pharmacy practice priorities, APTUK has an organisational pledge to continue this work of all themes through actions. The demographics of the Pharmacy Technician workforce continue to have a majority of white British registrants and identifying as female; the high-level data collated which is currently available on the GPHC website does not capture those who are actively enrolled on an approved course or qualification for Pharmacy Technicians."

The General Pharmaceutical Council (GPhC) has revealed it has received 25 whistleblowing disclosures between April 2021 and March 2022. The pharmacy regulator said, in its annual report, that it has concluded enquiries on 22 disclosures so far with a further three still under review. "We also concluded two qualifying disclosures that were raised during the previous reporting period," it said, adding: "The action GPhC took included a full investigation through established fitness to practise processes and follow-up action through its inspection network. "The former can result in any available outcome throughout the fitness to practise process. The latter can include guidance, a follow-up visit or an unexpected inspection." 12 concerns were investigated and concluded with no further action. Three were signposted to another organisation. The remaining seven cases were concluded by sharing information with inspection colleagues for follow up action. Of the two concerns from the previous reporting period, one was concluded with no further action and the other remains under investigation.

The result of the common registration assessment for pharmacists, held jointly by the General Pharmaceutical Council (GPhC) and Pharmaceutical Society of Northern Ireland (PSNI), have been published with an overall pass rate of 80 per cent. A total of 2,697 candidates sat the registration assessment in four countries on 29 June and 2,147 candidates passed the assessment. This summer's pass rate has fallen to 80 per cent compared with the 82 per cent pass rate for the summer 2021 registration assessment, and the 61 per cent pass rate for the Autumn 2021 registration assessment. GPhC chief executive Duncan Rudkin said: "We would like to congratulate the successful candidates and we look forward to them joining our register and continuing to the next stage of their career. "However, we appreciate that the June registration assessment was a difficult and stressful experience for many - and we are extremely sorry about the problems faced by a number of candidates on the day. "For those who did not pass, there is a guide on our website [PDF 255 KB] outlining all the options that may be available, such as provisional registration and the right to appeal. There are also links to organisations and resources that can provide support with mental health and wellbeing.

Out of the 2,805 students who sat for the common registration assessment test for pharmacists this June, approximately 2,150 have passed the exam, according to the General Pharmaceutical Council. It assesses pharmacy graduates' knowledge and skills to ensure safe and effective practice as pharmacists. This year, the pass rate was 77 per cent, slightly lower than the 80 per cent pass rate in June 2022, where 2,147 out of 2,697 candidates cleared the assessment, GPhC data showed. The exam comprises a written assessment testing pharmaceutical science and pharmacy practice knowledge and a practical assessment evaluating clinical skills and patient-facing competencies. Eligible candidates must complete an accredited pharmacy degree program and meet GPhC requirements. The assessment is conducted jointly by the General Pharmaceutical Council and the Pharmaceutical Society of Northern Ireland. "The assessment is a primary method for testing trainees' ability to apply knowledge and make professional judgments in pharmacy practice," said Mark Voce, Director of Education and Standards, GPhC. "This is crucial in assuring patients and the public that they are in safe hands."

The General Pharmaceutical Council (GPhC) has appointed a new provider, BTL Group Ltd, to conduct its common registration assessment sittings, which it holds jointly with the Pharmaceutical Society of Northern Ireland (PSNI). GPhC chief executive, Duncan Rudkin, said: "I'm pleased to confirm that we have appointed BTL as the supplier for the common registration assessment for the next 3 years after a thorough tender process. "The information provided by BTL during the tender process has given us the necessary assurance that they can support us in continuing to deliver a fair and robust assessment that tests candidates' ability to register as a pharmacist. We will now work closely with BTL on arrangements for the sittings in 2022, to make sure we can provide a positive experience for candidates." BTL has extensive experience of delivering services to a range of clients, including the Royal College of Paediatrics and Child Health and the Royal College of Ophthalmology. Before BTL, GPhC had a contract with Pearson Vue to conduct online assessment in 2021.

Eighty-one per cent of the National Pharmacy Association cohort of trainee pharmacists passed the General Pharmaceutical Council (GPhC)'s common registration assessment which took place in June. The NPA's team of learning and development pharmacists helped students prepare for the assessment with study days and mock exams. Celebrating the success of trainee pharmacists, it said: "The 81 per cent NPA pass rate reflected the comprehensive blended learning experience delivered by the NPA's team of learning and development pharmacists and that we were able to resume face-to-face study days for this cohort after the restrictions of lockdowns." Last month, the GPhC and Pharmaceutical Society of Northern Ireland (PSNI) published result of the common registration assessment for pharmacists with an overall pass rate of 80 per cent. A total of 2,697 candidates sat the registration assessment in four countries on 29 June and 2,147 candidates passed the assessment.

A total of 525 candidates have passed the common registration assessment for pharmacists held in November, the regulators GPhC and PSNI have announced on Tuesday. With 937 candidates sitting for the registration assessment, held jointly by the General Pharmaceutical Council (GPhC) and Pharmaceutical Society of Northern Ireland (PSNI) on 3 November, the pass rate was 56 per cent, down from the 61 per cent for the Autumn 2021. Among the GPhC candidates, 59 per cent were sitting for the first time, 30 per cent for the second time and 8 per cent for the third time. (The break-up was not available for the 3 per cent PSNI candidates.) In comparison, for the June sitting 89 per cent of candidates were sitting for the first time, 7 per cent were sitting for the second time and 4 per cent were sitting for the third time. "We would like to congratulate the successful candidates and we look forward to them joining our register and continuing to the next stage of their career," Duncan Rudkin, GPhC chief executive said.

The General Pharmaceutical Council has apologised for severe delays and disruptions during the June foundation registration assessment at five test centres in England on Wednesday (June 29). The pharmacy regulator said it has since "contacted the candidates affected via email to apologise for the disruption and the extra worry this will have caused. "We will also be issuing our usual survey for all candidates so we can hear directly from them about their experiences and have also asked candidates to get in touch if they would like individual advice." GPhC admitted that the worse sufferers were the candidates at a test centre in Nottingham "where the delay was severe and candidates were only able to start Paper 1 in the late afternoon". Extremely sorry In a statement, Duncan Rudkin, chief executive of the GPhC, said: "We are extremely sorry for the severe delays experienced by candidates in Nottingham today. This is completely unacceptable, and we fully appreciate the significant stress and disruption this must have caused for them in such a high-stakes assessment.

Pharmacists on the temporary register will be automatically removed on April 1, unless they have applied to rejoin the permanent register, the General Pharmaceutical Council has said. The government asked the GPhC and other pertinent health professional regulators to close temporary registers by March 31, 2024. According to the GPhC, this decision is based on the anticipation that the emergency conditions justifying the establishment of these temporary registers will cease after the approaching winter. The temporary register was established after the Health and Social Care Secretary asked the Council to utilise its emergency powers to swiftly register pharmacy professionals for their essential role in the national COVID-19 response. Pharmacists and pharmacy technicians who had previously opted to withdraw from the GPhC register or failed to renew their registration are now eligible for immediate re-registration, the regulator added.

New legislative orders approved by the Privy Council will give the General Pharmaceutical Council (GPhC) and Pharmaceutical Society of Northern Ireland (PSNI) powers to set professional standards for Responsible Pharmacists, Superintendent Pharmacists and Chief Pharmacists. The Pharmacy (Preparation and Dispensing Errors - Hospital (and Other Pharmacy Services) Order 2022 and the Pharmacy (Responsible Pharmacists, Superintendent Pharmacists etc.) Order 2022 have been published and are expected to come into force in December 2022. Trevor Patterson, Chief Executive of the Pharmaceutical Society NI said: "We have been working with our colleagues in the GPhC and Government for some time on these two pieces of important legislation and we are delighted they have now reached the statute books. "Both Orders enable and enhance the powers we, and the GPhC, have to define the roles and responsibilities of Responsible, Superintendent and Chief Pharmacists, respectively. They also create protections against criminal prosecution for hospital pharmacists where an inadvertent error is made either in dispensing or assembly, in certain defined circumstances, similar to the protections available to colleagues working in community/registered pharmacy settings. Provisions that allow the appointment of a Deputy Registrar for our organisation will also be introduced.

The General Pharmaceutical Council (GPhC) has published the results of the common registration assessment for aspiring pharmacists held on 2 November, 2023. An overall pass rate of 66 per cent was recorded this year, as compared to 56 per cent in 2022 and 61 per cent in 2021. A total of 1,067 candidates took the registration assessment, held jointly by the GPhC and Pharmaceutical Society of Northern Ireland (PSNI), of which 700 candidates cleared the assessment In 2022, 937 candidates sat the registration assessment of which 525 passed the assessment. Commenting on the results, GPhC Director of Education and Standards, Mark Voce, said: "I would like to congratulate all those who passed the November registration assessment and I look forward to them joining our register to continue to the next stage of their career. "There will be candidates who unfortunately did not pass the assessment. If this is the case, the information on our website outlines all the possible options of what to do next.

The General Pharmaceutical Council (GPhC) recently appointed a chief pharmacy officer and a chief enforcement officer on 26 October. Roz Gittins will be joining as chief pharmacy officer and deputy registrar whereas Dionne Spence as chief enforcement officer and deputy registrar from 3 January. The regulator confirmed that the new officers will "form the new executive structure of the GPhC". They will be working with the existing staff members Mark Voce, in his new role, is the chief strategy officer and deputy registrar and Jonathan Bennetts, will be the chief operating officer & deputy registrar. It is stated that Gittins is to serve as "the most senior member of the profession," offering pharmacy leadership throughout the GPhC.